4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)

Q: What does CUSIP 35104E100 represent in this 13F holders report?

CUSIP 35104E100 is the security identifier for FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share in Q2 2026?

22 institutional investors reported FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 35104E100

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, $0.0001 par value per share
Total 13F shares: 253,148
Total 13F value: $3,366,657
Share change: -301,515
SEC-reported price per share: $13.30
Number of holders: 22
Value change: -$2,625,458
Number of buys: 6
Number of sells: 10
Shares outstanding: 51,571,939

Security key

35104E100

Report period

Q2 2026

Institutions

Top holders

FDMT full security history Ownership snapshot Full 13F holder table 4D Molecular Therapeutics, Inc. SEC filings 4D Molecular Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 35104E100

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Janus Henderson Group Ltd.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

31 Mar 2026

13F 13D/G 3/4/5 Lead comparable stake: 10% 13D/G row: Janus Henderson Group Ltd. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.

Comparable ownership Top 5

Janus Henderson Group Ltd. 10%

BIOTECHNOLOGY VALUE FUND L P 10%

RA CAPITAL MANAGEMENT, L.P. 9.9%

GOLDMAN SACHS GROUP INC 7.5%

BlackRock, Inc. 6.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Janus Henderson Group Ltd.	13F 13D/G Company · JANUS HENDERSON GROUP PLC 13F 13D/G	10% from 13D/G	$48,868,164 5,247,151 shares	—	31 Mar 2026
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	10%	$52,609,747 5,346,519 shares	-$4,927,498	31 Mar 2026
RA CAPITAL MANAGEMENT, L.P.	3/4/5 13D/G 13F 10%+ Owner · Company 3/4/5 13D/G 13F	9.9% from 13D/G	$74,517,236 8,173,211 shares mixed-class rows	—	09 Dec 2024
GOLDMAN SACHS GROUP INC	13F 13D/G Company · THE GOLDMAN SACHS GROUP, INC. 13F 13D/G	7.5% from 13D/G	$39,152,628 4,205,438 shares	—	31 Mar 2026
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	6.6% from 13D/G	$38,592,771 4,145,303 shares	—	31 Mar 2026
Novo Holdings A/S	13F 13D/G Company 13F 13D/G	6.4% from 13D/G	$33,988,361 3,650,737 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

253,148

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

151

Q2 2026 holders

Holder diff

-129

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend